Outcomes of viral infection in hematology patients
Not Applicable
- Conditions
- Health Condition 1: B342- Coronavirus infection, unspecified
- Registration Number
- CTRI/2020/05/025092
- Lead Sponsor
- Science and Engineering Research Board SERB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Cases will be all patients with haematological disorders diagnosed to have COVID 19 infection
2) Controls will be patients with other viral respiratory infections.
3)If we are unable to get adequate controls, we will acquire de-identified data from the department database on patients who were diagnosed to have viral respiratory illness during 2018 â?? 2019. They will be matched as closely as possible for age [child vs adult], sex, chemotherapy vs transplant and underlying illness.
Exclusion Criteria
1) Patients with asymptomatic COVID-19
2) Patients in whom SARS-CoV-2 viral load at diagnosis is not available
3) Patients with a diagnosis of either bacterial or fungal respiratory infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the clinical profile and outcomes of COVID 19 infection in patients with <br/ ><br>Hematological disordersTimepoint: DAY 8
- Secondary Outcome Measures
Name Time Method To study the relationship between degree of immune suppression with outcomes <br/ ><br>2. To study the relationship between viral load and outcomes <br/ ><br>3. To compare the severity and outcomes of infection with COVID19 virus with other <br/ ><br>seasonal respiratory viral infections.Timepoint: Day 20